Biomet sales rise, but slower than expected
Biomet’s quarterly results are considered an indicator on the state of the orthopedic device industry because it reports results before most of its competitors.
Biomet’s quarterly results are considered an indicator on the state of the orthopedic device industry because it reports results before most of its competitors.
Dr. Alexander B. Niculescu, a psychiatrist at the IU School of Medicine, has won a five-year, $1.5 million grant from the National Institutes of Health to hunt for the presence of certain proteins in the blood that would indicate that a patient suffers from a mood disorder, which afflicts one in five Americans.
Indianapolis-based WellPoint Inc. and competing U.S. health insurers approved $10 billion in stock repurchases in the past year, a concern to investors who say buybacks failed to increase share prices and who want more spent on dividends.
The developer of an unfinished medical office complex on Binford Boulevard has filed for Chapter 11 bankruptcy protection in hopes it can retain control of the property and resume construction later this year.
In combination with chemotherapy, the drug failed to help colon-cancer patients in a European trial but did delay the spread of breast cancer in some patients with a certain type of aggressive tumor.
John Gause has grown the size of his benefits brokerage and consulting firm by more than half this year for one big reason: health care reform. He needs more hands on deck because his clients–employers–are facing a raft of new regulations with which they must comply.
The Indianapolis-based life insurer's investment portfolio held up through the recession, and the company reported record revenue and profit in 2009.
Getting 8,500 volunteers to where they're supposed to be along Interstate 70 relies on a system of color-coded passes. By 6 p.m. Thursday, they'll have planted 1,600 trees and 72,000 shrubs and perennials (with photo gallery).
Lucas Oil Products Inc. owners Forrest and Charlotte Lucas confirmed they were buying the property for $3 million at a news conference Wednesday afternoon. It will be used for “business activities and community functions.”
To date, most analysts say health reform turned out pretty well for the pharmaceutical industry. But a detailed analysis by Deloitte Consulting says the indirect effects of reform will deliver a gut punch to the industry that will lead to full-scale transformation akin to what the telecommunications world has seen over the past three decades.
Health insurers, including locally based WellPoint Inc. and Advantage Health Solutions, have been looking to work with health care providers to form accountable-care organizations. But they also worry that the accountable-care concept will become nothing more than a negotiating tactic by hospitals and doctors.
Drugmakers including Pfizer Inc., AstraZeneca, Bristol-Myers Squibb Co. and Eli Lilly and Co. may provide more than $2 billion in drug discounts to senior citizens next year under a deal pharmaceutical companies made with the White House.
The Indianapolis-based firm that helps seniors and their care givers navigate the health care system won a nearly $1.2 million grant from the National Institutes of Health.
Ash Brokerage Corp. and InSource Inc. have merged to create Ash InSource LLC, a company with annual fixed and equity-indexed annuity sales of more than $1 billion.
Rising costs aren't the only impact of reform, say panelists taking part in a Power Breakfast sponsored by Indianapolis Business Journal.
In this new age of health care, ushered in by President Obama’s signing in March of a sweeping health care reform law, health care players are encouraged to remove the gloves if they want to reap the benefits of reform.
Major health insurers, including Indianapolis-based Anthem, are being ordered to a hearing to explain why they are eliminating child-only policies.
Celesio’s Lloyds Pharmacy and Aah Pharmaceuticals businesses sold about 800,000 tablets of generic Zyprexa before agreeing in 2008 to halt sales, Lilly said in a complaint filed in the High Court in London.
The CEO is on his way out and the board has been dissolved at Rehabilitation Hospital of Indiana, as its owners—Clarian Health and St. Vincent Health—work to pull the hospital closer to their own operations.